Global Urticaria Drugs Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Urticaria Drugs Market was valued at $4.8 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 14.5% CAGR, to an estimated market size of $9.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global urticaria drugs market encompasses pharmaceutical treatments for acute and chronic urticaria (hives), including antihistamines, monoclonal antibodies, and anti-inflammatory medications. The scope includes both prescription and over-the-counter (OTC) drugs used to manage symptoms like wheals and angioedema, while excluding non-pharmacological skin treatments.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Urticaria Drugs Market in the period 2025-30:
- The maturation of the biologic pipeline is the primary growth driver, with next-generation assets like ligelizumab and dupilumab entering the market.
- Increasing global prevalence of allergic diseases is being driven by environmental irritants, pollution, and climate change.
- There is a significant shift toward personalized treatment approaches for patients who are refractory to standard first-line antihistamine therapies.
- Advances in diagnostic precision, including biomarker panels and basophil activation tests, are enabling earlier identification of eligible patients.
- The entry of biosimilars in mature markets is creating pricing pressures that paradoxically expand patient access to advanced therapies.
- Growing adoption of teledermatology and digital health platforms is improving treatment adherence and long-term disease control.
- Rising healthcare expenditure in emerging economies is improving access to specialized dermatology clinics and branded medications.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Monoclonal Antibodies (Biologics)
- Antihistamines
- Other Medications